By Maria Armental 

Medtronic PLC will book a $500 million charge in its second quarter tied to an internal restructuring following its $50 billion acquisition of Covidien PLC in January.

The restructuring, which largely resulted in a change to Medtronic's U.S. income taxes, frees up about $9.8 billion in cash and other investments to meet its financial targets, including cutting its debt-to-Ebitda ratio by the end of fiscal year 2018 while returning at least half of its free cash flow to investors through dividends and stock buybacks.

As part of the Covidien deal, Medtronic changed its headquarters from Minneapolis to Dublin, lowering its over all tax burden.

Write to Maria Armental at maria.armental@wsj.com

 

Subscribe to WSJ: http://online.wsj.com?mod=djnwires

(END) Dow Jones Newswires

September 28, 2015 17:54 ET (21:54 GMT)

Copyright (c) 2015 Dow Jones & Company, Inc.
Medtronic (NYSE:MDT)
Historical Stock Chart
From Mar 2024 to Apr 2024 Click Here for more Medtronic Charts.
Medtronic (NYSE:MDT)
Historical Stock Chart
From Apr 2023 to Apr 2024 Click Here for more Medtronic Charts.